December 9, 2022

FTX Slush Fund Bankrolled Bogus Studies To Hide Covid Therapeutics

FTX funded studies by means of TOGETHER Trial falsely claiming hydroxychloroquine, ivermectin weren’t efficient Covid treatments.

Clinical trials that will found therapeutic medications ivermectin and hydroxychloroquine were inadequate Covid treatments were financed by defunct crypto exchange FTX.

Amid the Covid outbreak, the FTX Foundation, helmed by now-infamous FTX TOP DOG Sam Bankman-Fried, bankrolled the clinical trial study group known as Together.

TogetherTrial. com homepage proudly displays FTX Foundation Group as its primary funder.

Together happened to run trials that purportedly targeted “ to identify effective repurposed therapies to prevent the disease progression of COVID-19. ”

“ Can we use existing medications to treat people with early diagnosed COVID-19? ” the Together group was supposedly tasked with figuring out.

Collectively investigated several medications which were being touted as possible cheap Covid remedies, among them anti-parasitic drug ivermectin and Hydroxychloroquine.

One such large-scale multi-author study published simply by Together in the New England Journal associated with Medicine viewed whether ivermectin could be effective at preventing Covid-19 hospitalization.

The study’s summary claimed: “ Treatment along with ivermectin did not result in a decrease incidence of medical admission to a hospital due to development of Covid-19 or of prolonged emergency department statement among outpatients with an earlier diagnosis of Covid-19. ”

The results of Together’s ivermectin study were reported earlier this year by mainstream mass media outlets, such as the New York Times , as one more toenail in the coffin proving the drug “ does not reduce risk of Covid hospitalization. ”

Discussing the study’s results in an interview with the Occasions , researcher Dr . Jesse Boulware knocked the drug, saying, “ There’s actually no sign of any benefit. ”

“ Now that people may dive into the details and the data, hopefully that will steer the majority of doctors away from ivermectin towards other therapies, ” Dr . Boulware told the particular Times .

The article also quoted Brigham and Can certainly Hospital clinical director Dr . Paul Sax, saying, “ At some point it will become a  waste of resources to carry on studying an unpromising technique. ”

The Cato Institute pushed back against Together’s clinical demo over the summer, noting the research should be scrutinized to see when researchers were biased, in addition to a host of other feasible study errors.

Together researchers also happened to run the same hit job upon hydroxychloroquine, ultimately coming to the particular conclusion that: “ In this particular randomized clinical trial, none hydroxychloroquine nor lopinavir-ritonavir demonstrated any significant benefit to get decreasing COVID-19– associated hospitalization or other secondary medical outcomes. ”

A chart of looked into interventions offered by Together displays studies into the possible efficacy of hydroxychloroquine and ivermectin were “ Ended early for futility . ”

Both hydroxychloroquine and ivermectin were advertised as inexpensive but effective alternative therapeutics that effectively treated Covid-19 infections for a lot of physicians during early therapy protocols.

The FTX Foundation has also mentioned they invested in “ next-generation coronavirus vaccines. ”

As the collapse of FTX continues to unfold, a wider picture is beginning to arise of it not just being a Democrat slush fund , but of it being a well-funded tool to stomp out competition and pave the way for Big Pharma treatments like experimental Covid vaccines.

Leave a Reply

Your email address will not be published. Required fields are marked *